OliX Pharmaceuticals Inc.

In News

OliX Pharmaceuticals Schedules In-Person IR Briefing for Individual Shareholders - The Globe and Mail

The Globe and Mail - Oct 15, 2026

OliX Pharmaceuticals Secures KRW 110 Billion Investment from BOLD, L’Oréal Corporate Venture Capital Fund, and Weiss, U.S. Hedge Fund - Business Wire

Business Wire - Jun 04, 2026

OliX Pharmaceuticals sinks after New Zealand rejects trial for macular drug - CHOSUNBIZ - Chosunbiz

Chosunbiz - Oct 13, 2026

OliX Pharma Raises $80M for siRNA Pipeline - AllSci

AllSci - Jun 04, 2026

Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals - GlobeNewswire

GlobeNewswire - Feb 03, 2026

OliX Phase 2a Trial for Eye Drug Rejected in New Zealand - Seoul Economic Daily

Seoul Economic Daily - Oct 12, 2026

OliX Pharmaceuticals to Highlight R&D and Strategy at Korea Premium Weeks IR Event - The Globe and Mail

The Globe and Mail - Oct 07, 2026

OliX’s OLX501A Demonstrates Greater Visceral Fat Reduction Relative to a Global Comparator in Obese Non-Human Primates - Business Wire

Business Wire - Jul 30, 2026

OliX Pharmaceuticals secures KRW 110 billion investment from L’Oréal venture fund and Weiss Asset Management - Global Cosmetics News

Global Cosmetics News - Jun 05, 2026

Bio Korea 2026 kicks off with spotlight on oligonucleotides - BioWorld News

BioWorld News - May 05, 2026

OliX halts New Zealand macular trial, pursues approvals in Australia, Korea - CHOSUNBIZ - Chosunbiz

Chosunbiz - Oct 12, 2026

OliX Pharmaceuticals Announces Positive Results from a Phase 2a Trial of OLX10010 for Hypertrophic Scar Treatment - BioSpace

BioSpace - Apr 28, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment